275 related articles for article (PubMed ID: 21854684)
41. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
Cross-Disorder Group of the Psychiatric Genomics Consortium
Lancet; 2013 Apr; 381(9875):1371-1379. PubMed ID: 23453885
[TBL] [Abstract][Full Text] [Related]
42. Genes regulated by BCL11B during T-cell development are enriched for de novo mutations found in schizophrenia patients.
Fahey L; Donohoe G; Broin PÓ; Morris DW
Am J Med Genet B Neuropsychiatr Genet; 2020 Sep; 183(6):370-379. PubMed ID: 32729240
[TBL] [Abstract][Full Text] [Related]
43. Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium.
Zhang T; Li J; Yu H; Shi Y; Li Z; Wang L; Wang Z; Lu T; Wang L; Yue W; Zhang D
PLoS One; 2018; 13(6):e0198690. PubMed ID: 29894498
[TBL] [Abstract][Full Text] [Related]
44. Expression analysis and genotyping of DGKZ: a GWAS-derived risk gene for schizophrenia.
Alinaghi S; Alehabib E; Johari AH; Vafaei F; Salehi S; Darvish H; Ghaedi H
Mol Biol Rep; 2019 Aug; 46(4):4105-4111. PubMed ID: 31087244
[TBL] [Abstract][Full Text] [Related]
45. Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies.
Mocellin S; Tropea S; Benna C; Rossi CR
BMC Med; 2018 Feb; 16(1):20. PubMed ID: 29455641
[TBL] [Abstract][Full Text] [Related]
46. Analysis of the joint effect of SNPs to identify independent loci and allelic heterogeneity in schizophrenia GWAS data.
Polushina T; Giddaluru S; Bettella F; Espeseth T; Lundervold AJ; Djurovic S; Cichon S; Hoffmann P; Nöthen MM; Steen VM; Andreassen OA; Le Hellard S
Transl Psychiatry; 2017 Dec; 7(12):1289. PubMed ID: 29249828
[TBL] [Abstract][Full Text] [Related]
47. Paradox of schizophrenia genetics: is a paradigm shift occurring?
Doi N; Hoshi Y; Itokawa M; Yoshikawa T; Ichikawa T; Arai M; Usui C; Tachikawa H
Behav Brain Funct; 2012 May; 8():28. PubMed ID: 22650965
[TBL] [Abstract][Full Text] [Related]
48. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
[TBL] [Abstract][Full Text] [Related]
49. Comprehensive analysis of schizophrenia-associated loci highlights ion channel pathways and biologically plausible candidate causal genes.
Pers TH; Timshel P; Ripke S; Lent S; Sullivan PF; O'Donovan MC; Franke L; Hirschhorn JN;
Hum Mol Genet; 2016 Mar; 25(6):1247-54. PubMed ID: 26755824
[TBL] [Abstract][Full Text] [Related]
50. Biological insights from 108 schizophrenia-associated genetic loci.
Schizophrenia Working Group of the Psychiatric Genomics Consortium
Nature; 2014 Jul; 511(7510):421-7. PubMed ID: 25056061
[TBL] [Abstract][Full Text] [Related]
51. Widespread signatures of positive selection in common risk alleles associated to autism spectrum disorder.
Polimanti R; Gelernter J
PLoS Genet; 2017 Feb; 13(2):e1006618. PubMed ID: 28187187
[TBL] [Abstract][Full Text] [Related]
52. Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population.
Pal P; Mihanović M; Molnar S; Xi H; Sun G; Guha S; Jeran N; Tomljenović A; Malnar A; Missoni S; Deka R; Rudan P
Croat Med J; 2009 Aug; 50(4):361-9. PubMed ID: 19673036
[TBL] [Abstract][Full Text] [Related]
53. Systematic re-evaluation of genes from candidate gene association studies in migraine using a large genome-wide association data set.
de Vries B; Anttila V; Freilinger T; Wessman M; Kaunisto MA; Kallela M; Artto V; Vijfhuizen LS; Göbel H; Dichgans M; Kubisch C; Ferrari MD; Palotie A; Terwindt GM; van den Maagdenberg AM;
Cephalalgia; 2016 Jun; 36(7):604-14. PubMed ID: 25633374
[TBL] [Abstract][Full Text] [Related]
54. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations.
Lasky-Su J; Neale BM; Franke B; Anney RJ; Zhou K; Maller JB; Vasquez AA; Chen W; Asherson P; Buitelaar J; Banaschewski T; Ebstein R; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Sonuga-Barke E; Steinhausen HC; Taylor E; Daly M; Laird N; Lange C; Faraone SV
Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1345-54. PubMed ID: 18821565
[TBL] [Abstract][Full Text] [Related]
55. Genetic Markers of Human Evolution Are Enriched in Schizophrenia.
Srinivasan S; Bettella F; Mattingsdal M; Wang Y; Witoelar A; Schork AJ; Thompson WK; Zuber V; ; Winsvold BS; Zwart JA; Collier DA; Desikan RS; Melle I; Werge T; Dale AM; Djurovic S; Andreassen OA
Biol Psychiatry; 2016 Aug; 80(4):284-292. PubMed ID: 26681495
[TBL] [Abstract][Full Text] [Related]
56. Dissociation of accumulated genetic risk and disease severity in patients with schizophrenia.
Papiol S; Malzahn D; Kästner A; Sperling S; Begemann M; Stefansson H; Bickeböller H; Nave KA; Ehrenreich H
Transl Psychiatry; 2011 Oct; 1(10):e45. PubMed ID: 22833191
[TBL] [Abstract][Full Text] [Related]
57. The role of genes affected by human evolution marker GNA13 in schizophrenia.
Xiang B; Yang J; Zhang J; Yu M; Huang C; He W; Lei W; Chen J; Liu K
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 98():109764. PubMed ID: 31676466
[TBL] [Abstract][Full Text] [Related]
58. Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia.
Devor A; Andreassen OA; Wang Y; Mäki-Marttunen T; Smeland OB; Fan CC; Schork AJ; Holland D; Thompson WK; Witoelar A; Chen CH; Desikan RS; McEvoy LK; Djurovic S; Greengard P; Svenningsson P; Einevoll GT; Dale AM
Mol Psychiatry; 2017 Jun; 22(6):792-801. PubMed ID: 28348379
[TBL] [Abstract][Full Text] [Related]
59. A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS data.
Wang Q; Chen R; Cheng F; Wei Q; Ji Y; Yang H; Zhong X; Tao R; Wen Z; Sutcliffe JS; Liu C; Cook EH; Cox NJ; Li B
Nat Neurosci; 2019 May; 22(5):691-699. PubMed ID: 30988527
[TBL] [Abstract][Full Text] [Related]
60. Integration analysis of methylation quantitative trait loci and GWAS identify three schizophrenia risk variants.
Yu H; Cheng W; Zhang X; Wang X; Yue W
Neuropsychopharmacology; 2020 Jun; 45(7):1179-1187. PubMed ID: 31910432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
